Press Releases

Dr. Matthew Barth accepts a $100,000 grant with Roswell Park colleagues, Hyundai dealers
Wednesday, July 17, 2019

BUFFALO, NY –  Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announced a $100,000 Hyundai Impact Award Grant to Roswell Park Comprehensive Cancer Center to continue its long-standing fight against pediatric cancer. The center is one of 77 recipients receiving a combined $16 million in new grants this year to develop innovative approaches to finding a cure for the disease.

Presidential Early Career Award for Scientists and Engineers is highest scientific honor bestowed by federal government
Monday, July 15, 2019

BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center’s Binnian Wei, PhD, has received a presidential award recognizing his scientific achievements and future promise. President Donald J.

Department formerly known as Pastoral Care celebrates 20 years under new name: Spiritual Care
Tuesday, July 9, 2019

BUFFALO, N.Y. — Two decades of support, and a new name to follow. For 20 years, the Department of Pastoral Care has supported the mission of Roswell Park Comprehensive Cancer Center through its integrative, interfaith approach to wellness, and providing ministry and care for the spirit of patients of all faith traditions. Reaching such a milestone in 2019, the Department of Pastoral Care has been renamed the Department of Spiritual Care.

Wednesday, June 26, 2019

BUFFALO, N.Y. — Two new leadership positions at Roswell Park Comprehensive Cancer Center are poised to continue our ongoing focus on complete, patient-centric clinical care.

Saturday, June 22, 2019

The Ride For Roswell presented by the West Herr Automotive Group welcomed 7,940 riders and 2,200 volunteers this weekend – the event’s largest turnout since 2015.

Wednesday, June 19, 2019
A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration (FDA) for patients with an aggressive form of non-Hodgkin lymphoma. On June 10, the FDA granted accelerated approval to polatuzumab vedotin as part of a new chemotherapy/immunotherapy treatment combination for patients with relapsed or refractory diffuse large B-cell lymphoma.
Thursday, June 13, 2019
Jens Hillengass, MD, Chief of Myeloma at Roswell Park, led an International Myeloma Working Group (IMWG) effort to compile new recommendations for imaging techniques that offer more sensitive and accurate diagnosis and monitoring for patients with multiple myeloma and other plasma-cell disorders.
Friday, June 7, 2019

BUFFALO, N.Y. — The longtime leader of Roswell Park Comprehensive Cancer Center’s radiation medicine program has become the latest official from the Buffalo cancer center to be named to a national healthcare advisory board.

Wednesday, June 5, 2019
Simply Pierogi has launched a three-year partnership with Roswell Park Comprehensive Cancer Center to benefit the Courage of Carly Fund.